Third, novel strategies inhibit the expressions of MMP-9 and MMP-2 and thus reduce HCC invasion, which can result in lower TNM stage in patients and lower tumor metastasis recurrence rate. The gene discussed is MMP9; the disease is hepatocellular carcinoma.